Starling Oncology, Inc. Acquisitions, Net of Cash Acquired
Starling Oncology, Inc. (STLN) reported Acquisitions, Net of Cash Acquired of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-26.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired · last filed 2025-03-26
- Starling Oncology, Inc. payments to acquire businesses, net of cash acquired for the quarter ending 2024-12-31 was $0.00, a 100.00% decline year-over-year.
- Starling Oncology, Inc. payments to acquire businesses, net of cash acquired for the quarter ending 2024-09-30 was $0.00.
- Starling Oncology, Inc. payments to acquire businesses, net of cash acquired for the quarter ending 2023-12-31 was $156.00K, a 66.81% decline year-over-year.
- Starling Oncology, Inc. payments to acquire businesses, net of cash acquired for the quarter ending 2023-09-30 was $0.00.
- Starling Oncology, Inc. payments to acquire businesses, net of cash acquired for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- Starling Oncology, Inc. payments to acquire businesses, net of cash acquired for fiscal 2023 was $4.46M, a 48.05% decline from fiscal 2022.
- Starling Oncology, Inc. payments to acquire businesses, net of cash acquired for fiscal 2022 was $8.58M, a 5.82% decline from fiscal 2021.
- Starling Oncology, Inc. payments to acquire businesses, net of cash acquired for fiscal 2021 was $9.11M, a 5971.33% increase from fiscal 2020.
| Period end | Payments to Acquire Businesses, Net of Cash Acquired 3 month | Payments to Acquire Businesses, Net of Cash Acquired 6 month | Payments to Acquire Businesses, Net of Cash Acquired 9 month | Payments to Acquire Businesses, Net of Cash Acquired 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-26 | $0.00 derived: sum of 2 quarters · filed 2025-03-26 | $0.00 10-K · filed 2025-03-26 | |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $0.00 10-Q · filed 2024-11-13 | ||
| 2024-06-30 | $0.00 10-Q · filed 2024-08-13 | |||
| 2023-12-31 | $156.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-26 | $156.00K derived: sum of 2 quarters · filed 2025-03-26 | $4.46M 10-K · filed 2025-03-26 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $4.30M 10-Q · filed 2024-11-13 | ||
| 2023-06-30 | $4.30M 10-Q · filed 2024-08-13 | |||
| 2022-12-31 | $470.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | -$343.00K derived: sum of 2 quarters · filed 2024-03-28 | $8.58M derived: sum of 3 quarters · filed 2024-03-28 | $8.58M 10-K · filed 2024-03-28 |
| 2022-09-30 | -$813.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $8.11M derived: sum of 2 quarters · filed 2023-11-08 | $8.11M 10-Q · filed 2023-11-08 | $16.39M derived: sum of 4 quarters · filed 2023-11-08 |
| 2022-06-30 | $8.92M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $8.92M 10-Q · filed 2023-08-09 | $17.20M derived: sum of 3 quarters · filed 2023-08-09 | $17.20M derived: sum of 4 quarters · filed 2023-08-09 |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-10 | $8.28M derived: sum of 2 quarters · filed 2023-03-16 | $8.28M derived: sum of 3 quarters · filed 2023-03-16 | $8.28M derived: sum of 4 quarters · filed 2023-03-16 |
| 2021-12-31 | $8.28M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $8.28M derived: sum of 2 quarters · filed 2023-03-16 | $8.28M derived: sum of 3 quarters · filed 2023-03-16 | $9.11M 10-K · filed 2023-03-16 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $0.00 derived: sum of 2 quarters · filed 2022-11-09 | $827.00K 10-Q · filed 2022-11-09 | |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $827.00K 10-Q · filed 2022-08-09 | ||
| 2021-03-31 | $827.00K 10-Q · filed 2022-05-10 | |||
| 2020-12-31 | $150.00K 10-K · filed 2022-03-11 |